Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. RKDA
RKDA logo

RKDA Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
2.199
Open
2.040
VWAP
1.98
Vol
46.53K
Mkt Cap
3.53M
Low
1.703
Amount
92.02K
EV/EBITDA(TTM)
--
Total Shares
1.73M
EV
1.06M
EV/OCF(TTM)
--
P/S(TTM)
0.54
Arcadia Biosciences, Inc. is a producer and marketer of plant-based health and wellness products. The Company’s product portfolio includes Zola Coconut Water (Zola) and Agronomic Wheat Traits. Zola is a natural, 100% coconut water. Zola is a non-genetically modified organisms (non-GMO) project verified and only contains 60 calories per serving. Zola flavors include original, original with pulp, espresso, lime and pineapple. The recipe with Zola includes smoothies, desserts, cocktails and mocktails, and bowls. It has developed a portfolio of non-GMO specialty wheat traits to offer healthier, nutrient-rich wheat options while providing the same baking quality, taste, and texture as traditional wheat. Its non-GMO Reduced Gluten High Fiber Wheat has fewer allergenic glutens and higher fiber than traditional wheat, while its non-GMO Extended Shelf-Life Wheat extends the shelf life of milled whole wheat flour.
Show More

Events Timeline

(ET)
2026-01-28
06:10:00
Arcadia Biosciences Files to Sell 1.67M Shares of Common Stock
select
2026-01-20 (ET)
2026-01-20
06:10:00
Rockwell Medical Sees Q4 Gross Margin Rise to 22%
select
2026-01-12 (ET)
2026-01-12
08:50:00
Arcadia Biosciences Issues Preferred Investment Options, Raises Approximately $2.1M
select
2026-01-05 (ET)
2026-01-05
06:10:00
Rockwell Medical Extends Agreement with Major US Dialysis Provider to December 31, 2026
select
2025-12-26 (ET)
2025-12-26
16:10:00
Stocks Fluctuate Near All-Time Highs, S&P 500 Slightly Declines
select
2025-12-26
08:10:00
Arcadia CEO Announces Evaluation of Strategic Alternatives to Create Shareholder Value
select
2025-12-26
08:10:00
Arcadia Biosciences Terminates Securities Exchange Agreement with Roosevelt Resources
select
2025-12-15 (ET)
2025-12-15
07:00:00
Rekor Systems Prices 8,571,428 Units Direct Offering at $1.75 Each
select
2025-05-08 (ET)
2025-05-08
08:11:48
Arcadia Biosciences reports Q1 revenue $1.2M vs $987k last yea
select
2024-11-12 (ET)
2024-11-12
16:48:57
Arcadia Biosciences reports Q3 EPS ($1.18), consensus (81c)
select

News

NASDAQ.COM
4.5
2025-12-26NASDAQ.COM
Arcadia Biosciences (RKDA) Terminates Agreement with Roosevelt Resources, Resumes Strategic Evaluation
  • Termination of Agreement: Arcadia Biosciences announced the termination of its Securities Exchange Agreement with Roosevelt Resources, which previously aimed for a business combination, potentially impacting the company's strategic direction and market confidence.
  • Asset Evaluation: Arcadia retains approximately 2.7 million shares of Above Food Ingredients Inc. common stock and believes it is entitled to additional compensation related to the May 2024 sale of GoodWheatTM, indicating potential in asset management.
  • Operational Optimization: Over the past two and a half years, Arcadia has streamlined operations and significantly reduced operating expenses, successfully growing the Zola coconut water brand, demonstrating resilience and adaptability in market competition.
  • Stock Price Surge: In pre-market trading, RKDA shares rose by 8.96% to $3.31, reflecting investor optimism regarding the company's future strategic adjustments.
Globenewswire
4.5
2025-12-26Globenewswire
Arcadia Biosciences Terminates Agreement with Roosevelt Resources, Resumes Strategic Evaluation
  • Agreement Termination: Arcadia Biosciences received a notice on December 24, 2025, from Roosevelt Resources terminating the Securities Exchange Agreement dated December 4, 2024, which prevents the planned business combination, potentially impacting the company's strategic direction.
  • Strategic Evaluation Resumption: CEO T.J. Schaefer stated that the company will resume evaluating strategic alternatives to create shareholder value, indicating a search for new growth opportunities amid the ongoing success of its Zola coconut water brand.
  • Asset Holdings: Arcadia currently owns approximately 2.7 million shares of Above Food Ingredients Inc. and believes it is entitled to additional compensation related to the May 2024 sale of GoodWheatTM, which could support future strategic transactions.
  • Financial Challenges: The company faces funding needs and may require additional equity or debt financing to support future operations; if adequate funding is not secured, it may need to reduce or suspend activities, potentially leading to bankruptcy risks that could adversely affect its financial condition.
Newsfilter
3.5
2025-12-04Newsfilter
Rigaku Launches XTRAIA MF-3400 for Semiconductor Measurement, Anticipates Over JPY 6 Billion Sales by 2026
  • Surging Market Demand: As generative AI and data centers expand, the semiconductor market's demand for high-performance, energy-efficient chips is skyrocketing, and Rigaku's launch of the XTRAIA MF-3400 will significantly enhance production efficiency to meet this trend.
  • Technological Innovation: The XTRAIA MF-3400 dramatically increases the number of wafers measurable per hour by doubling the X-ray dose and integrating a new transport system, enabling high-accuracy evaluation of complex semiconductor structures essential for mass production of next-generation memory chips.
  • Integrated Multifunctionality: This device incorporates three analytical functions—fluorescent X-rays, X-ray reflectance, and X-ray diffraction—allowing multiple measurements on a single device, which enhances production line flexibility and efficiency to cater to diverse manufacturing needs.
  • Future Prospects: Rigaku anticipates that combined with its predecessor, the XTRAIA MF-3400 will exceed JPY 6 billion in sales by FY2026, with plans for a sustainable growth rate of 20% in FY2027, showcasing strong application potential in new material and process fields.
SeekingAlpha
9.5
2025-11-10SeekingAlpha
Arcadia Biosciences Reports GAAP EPS of $0.63, Exceeding Estimates by $1.29; Revenue of $1.3M Falls Short by $0.1M
  • Earnings Performance: Arcadia Biosciences reported a Q3 GAAP EPS of $0.63, exceeding expectations by $1.29.

  • Revenue Trends: The company's revenue for the quarter was $1.3M, a 15.6% decrease year-over-year, missing estimates by $0.1M.

  • Zola® Growth: Year-to-date revenues for Zola® have increased by 26% compared to the previous year.

  • Financial Stability: Arcadia's gross profit margins have surpassed 30% for the 11th consecutive quarter, with a slight decline in cash balance to $1.1M.

PRnewswire
7.0
2025-10-09PRnewswire
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates HRZN, RKDA, HNI on Behalf of Shareholders
  • Investigation of Mergers: Halper Sadeh LLC is investigating potential violations of federal securities laws related to mergers involving Horizon Technology Finance Corporation, Arcadia Biosciences, Inc., and HNI Corporation.

  • Shareholder Rights: The firm encourages shareholders from these companies to contact them for information on their legal rights and options, emphasizing that they operate on a contingent fee basis with no upfront costs for clients.

Globenewswire
7.0
2025-10-08Globenewswire
Shareholder Notice: Legal Investigation Initiated for the Merger Involving HRZN, HNI, GDST, and RKDA
  • Class Action Firm Recognition: Monteverde & Associates PC, led by attorney Juan Monteverde, is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report and has successfully recovered millions for shareholders.

  • Ongoing Investigations: The firm is currently investigating several mergers involving Horizon Technology Finance Corporation, HNI Corporation, Goldenstone Acquisition Limited, and Arcadia Biosciences, offering free consultations for shareholders concerned about these transactions.

Valuation Metrics

The current forward P/E ratio for Arcadia Biosciences Inc (RKDA.O) is -0.87, compared to its 5-year average forward P/E of -1.55. For a more detailed relative valuation and DCF analysis to assess Arcadia Biosciences Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-1.55
Current PE
-0.87
Overvalued PE
-0.63
Undervalued PE
-2.47

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.29
Current EV/EBITDA
0.89
Overvalued EV/EBITDA
1.18
Undervalued EV/EBITDA
-0.60

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.40
Current PS
0.40
Overvalued PS
2.72
Undervalued PS
0.09

Financials

AI Analysis
Annual
Quarterly

Whales Holding RKDA

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Arcadia Biosciences Inc (RKDA) stock price today?

The current price of RKDA is 2.03 USD — it has decreased -0.49

What is Arcadia Biosciences Inc (RKDA)'s business?

Arcadia Biosciences, Inc. is a producer and marketer of plant-based health and wellness products. The Company’s product portfolio includes Zola Coconut Water (Zola) and Agronomic Wheat Traits. Zola is a natural, 100% coconut water. Zola is a non-genetically modified organisms (non-GMO) project verified and only contains 60 calories per serving. Zola flavors include original, original with pulp, espresso, lime and pineapple. The recipe with Zola includes smoothies, desserts, cocktails and mocktails, and bowls. It has developed a portfolio of non-GMO specialty wheat traits to offer healthier, nutrient-rich wheat options while providing the same baking quality, taste, and texture as traditional wheat. Its non-GMO Reduced Gluten High Fiber Wheat has fewer allergenic glutens and higher fiber than traditional wheat, while its non-GMO Extended Shelf-Life Wheat extends the shelf life of milled whole wheat flour.

What is the price predicton of RKDA Stock?

Wall Street analysts forecast RKDA stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for RKDA is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Arcadia Biosciences Inc (RKDA)'s revenue for the last quarter?

Arcadia Biosciences Inc revenue for the last quarter amounts to 1.30M USD, decreased -15.29

What is Arcadia Biosciences Inc (RKDA)'s earnings per share (EPS) for the last quarter?

Arcadia Biosciences Inc. EPS for the last quarter amounts to 0.62 USD, decreased -152.54

How many employees does Arcadia Biosciences Inc (RKDA). have?

Arcadia Biosciences Inc (RKDA) has 9 emplpoyees as of March 11 2026.

What is Arcadia Biosciences Inc (RKDA) market cap?

Today RKDA has the market capitalization of 3.53M USD.